End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients
Crossref DOI link: https://doi.org/10.1007/s12072-016-9735-4
Published Online: 2016-05-24
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahn, Joseph
Bhuket, Taft
Mosadeghi, Sasan
Frenette, Catherine
Liu, Benny
Wong, Robert J.
Text and Data Mining valid from 2016-05-24